Oliver Planz is Professor for Immunology and Cell Biology and heads the group “Translational Immunology of Infection” in the Department of Immunology at the University of Tuebingen. He is an expert in antiviral research and translational preclinical R&D up to clinical studies and CSO for Atriva Therapeutics GmbH.
Oliver Planz
Professor, Head of Immune Response to Infection
Eberhard Karls University, Department of Immunology
